155 related articles for article (PubMed ID: 3110943)
1. Long-term efficacy and safety of auranofin: a review of clinical experience.
Blodgett RC; Pietrusko RG
Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
[TBL] [Abstract][Full Text] [Related]
2. Postmarketing experience with auranofin in the Federal Republic of Germany.
Schattenkirchner M; Missler B; Mulz D
Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683
[TBL] [Abstract][Full Text] [Related]
3. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis?
Bandilla K; Missler B; Klein-Reesink B
Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777
[TBL] [Abstract][Full Text] [Related]
4. Auranofin.
Davis P
Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
[TBL] [Abstract][Full Text] [Related]
5. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
Davis P; Menard H; Thompson J; Harth M; Beaudet F
J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
[TBL] [Abstract][Full Text] [Related]
6. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study.
Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC
Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682
[TBL] [Abstract][Full Text] [Related]
8. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
[TBL] [Abstract][Full Text] [Related]
9. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
[TBL] [Abstract][Full Text] [Related]
10. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
[TBL] [Abstract][Full Text] [Related]
11. An analysis of worldwide safety experience with auranofin.
Heuer MA; Pietrusko RG; Morris RW; Scheffler BJ
J Rheumatol; 1985 Aug; 12(4):695-9. PubMed ID: 3932651
[TBL] [Abstract][Full Text] [Related]
12. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
[TBL] [Abstract][Full Text] [Related]
13. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
Leonard PA; Bienz SR; Clegg DO; Ward JR
J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
16. A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis.
Rau R; Schattenkirchner M; Muller-Fassbender H; Kaik B; Zeidler H; Missler B
Clin Rheumatol; 1990 Dec; 9(4):461-74. PubMed ID: 2128475
[TBL] [Abstract][Full Text] [Related]
17. An open study on the efficacy and safety of auranofin in treating psoriatic arthritis.
Dequeker J; Gevers G
Scand J Rheumatol Suppl; 1986; 63():85-95. PubMed ID: 3474779
[TBL] [Abstract][Full Text] [Related]
18. [Prospective clinical study of the combination therapy of auranofin and methotrexate for rheumatoid arthritis--a multi-center study].
Kashiwazaki S; Akizuki M; Ichikawa Y; Uchida S; Kondo H; Torikai K; Hayashi T; Hara M; Matsuoka Y
Ryumachi; 1996 Jun; 36(3):528-44. PubMed ID: 8779790
[TBL] [Abstract][Full Text] [Related]
19. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
[TBL] [Abstract][Full Text] [Related]
20. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.
Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D
J Rheumatol; 1991 Aug; 18(8):1240-2. PubMed ID: 1941832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
